?
Can CA1 subfield volumetry on 7T MRI serve as a primary endpoint for tau-targeting clinical trials?
active
open question
Created: 2026-04-25T20:28:25
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-20cc6a4b-2b37-49ea-b1cb-8b
Open Question
open
Wiki: cell-types-hippocampal-ca1-pyramidal-aging-tauopathy
Can CA1 subfield volumetry on 7T MRI serve as a primary endpoint for tau-targeting clinical trials?
Importance Elo
1500
Field Rank
Rank #391 in cell
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page cell-types-hippocampal-ca1-pyramidal-aging-tauopathy
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:28:25.742735'} |
| field_tag | cell |
| source_id | cell-types-hippocampal-ca1-pyramidal-aging-tauopathy |
| sub_field | types-hippocampal-ca1-pyramidal-aging-tauopathy |
| source_kind | wiki |
| question_hash | 3bf9eb7e60e1512b9373b2b48075c38e0f6fcef8ee264c5af7a0c742e21589c8 |
| question_text | Can CA1 subfield volumetry on 7T MRI serve as a primary endpoint for tau-targeting clinical trials? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page cell-types-hippocampal-ca1-pyramidal-aging-tauopathy |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.